Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy.
about
Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficienciesEpstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infectionHost factors and early treatments to restrict paediatric HIV infection and early disease progressionImmune activation and paediatric HIV-1 disease outcomeCD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individualsEarly ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal DatasetDamaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from UgandaMicrobial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infectionMucosal immunity in human and simian immunodeficiency lentivirus infectionsInterferon-alpha administration enhances CD8+ T cell activation in HIV infectionBiomarkers of immune dysfunction in HIV.The mucosal barrier and immune activation in HIV pathogenesisT Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens.The immunological and virological consequences of planned treatment interruptions in children with HIV infection.Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited settingSuboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartmentNationwide Study of Cancer in HIV-Infected Taiwanese Children in 1998-2009.Serum (1→3)-β-D-glucan levels in HIV-infected individuals are associated with immunosuppression, inflammation, and cardiopulmonary functionMicrobial translocation across the GI tractMicrobial translocation, immune activation, and HIV disease.Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy.Premature aging and immune senescence in HIV-infected children.Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.Role of intestinal mucosal integrity in HIV transmission to infants through breast-feeding: the BAN studyCombination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection.Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infectionShort communication: Evidence that microbial translocation occurs in HIV-infected children in the United Kingdom.Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia.Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection.Microbial translocation in HIV infection: causes, consequences and treatment opportunities.Impact of Vaccination on Distribution of T Cell Subsets in Antiretroviral-Treated HIV-Infected Children.Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children.Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents.
P2860
Q26827084-6067131A-289F-40BD-82A6-BA1088E78433Q27022706-D26A5E6B-5E07-4C5E-8832-55BCE965E61EQ28082411-9F4F9FA5-32A9-4460-A912-8F8535E5CE84Q28086888-1BE272EC-777B-4A5F-B755-CA878AE6B9E9Q28751971-04D34CC1-27D3-478E-8B68-1C9B6E577D43Q29999998-9E0ED770-524A-4470-BC3D-DB62B5277F40Q33680743-92FF27D9-7826-4125-9903-B9FA7B9DC784Q33805240-629EEBEF-3B8B-4553-94D1-5839BD4F318CQ33924628-54D35807-4626-48DC-A548-E10F812E00AFQ33936619-0645D9A3-48ED-43F4-B894-68008FC55F0FQ34131265-8E72D455-7273-4048-A984-A1EC70FCA5C1Q34145979-8AAB0BC9-2BDA-4E0C-9B4E-73EEDE8FF389Q34546742-EA0E40F2-105F-489D-A7F6-79F94C025BF9Q34606638-A8E09B00-BCF2-42E4-82F6-475E624F2EA6Q34805000-7F692B60-F8E5-406F-845A-E5ED6685F411Q35032305-0E7FC6F5-3610-4B8B-A877-02D74AD384D4Q35283132-A3E294CD-65C8-483B-9848-FCD3FC910F4DQ35895763-49A81F40-9EFC-48F6-9022-A98BF981442FQ35897560-480BA90D-C877-4CC6-8254-07197D21586BQ36389079-426972E9-7BAE-4862-A583-A2C6878F9381Q36441742-0A65A2E1-0DB8-40D2-BDBE-669F52AECF96Q36501286-2D4D264C-BF9F-4FE7-8554-D040F4BF7FB9Q36829108-3E3FDD4A-4697-4D8D-9D05-1D194E4BEF5EQ36903898-40682086-5D27-4A86-8F1B-A399DD43941CQ36915902-C65E250F-96AD-436C-9C2F-E38FFCEDC6BEQ37037065-D5AD46C2-4C84-48F8-B002-671D20E2B433Q37247467-42E96A47-EB97-4862-9186-6AB3808C6F25Q37309633-9B006F9C-0757-422C-A98C-26AB45693684Q37359248-3A806272-81E9-44CE-9474-FD89C8A54645Q37435942-DD56E25E-49E8-4028-9C00-FDC8D6373A43Q37862747-5FB844A8-0D20-4C4E-A14C-153EB8C85D08Q38034068-0D135923-801D-4A7F-BC57-C5D64425A19AQ40128331-659A0EA4-8880-46DC-B1A3-95BC161C5CB6Q40548877-589CBE02-2CF1-4C1A-BE66-75CD5BF6B468Q41677169-5ABF83E0-04EC-4EEA-BA11-F2A687562520Q44442856-77BE4B31-2AEA-4A72-BD76-149EA20BBB2BQ48330936-2A5C0050-E786-459F-8A52-527E470C5AF3
P2860
Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Immune reconstitution in human ...... es to anti-retroviral therapy.
@en
Immune reconstitution in human ...... es to anti-retroviral therapy.
@nl
type
label
Immune reconstitution in human ...... es to anti-retroviral therapy.
@en
Immune reconstitution in human ...... es to anti-retroviral therapy.
@nl
prefLabel
Immune reconstitution in human ...... es to anti-retroviral therapy.
@en
Immune reconstitution in human ...... es to anti-retroviral therapy.
@nl
P2093
P2860
P1476
Immune reconstitution in human ...... es to anti-retroviral therapy.
@en
P2093
C Giaquinto
D Vendrame
M Zanchetta
P2860
P304
P356
10.1111/J.1365-2249.2007.03526.X
P577
2007-10-22T00:00:00Z